Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Epogen was produced by Amgen.

Higher overseas sales push up J&J Q2 results

In Q1 2007, an FDA regulatory panel demanded warning labels to be upgraded on all marketed anaemia drugs: J&J's Procrit and Amgen's Aranesp (darbepoetin alfa) and Epogen (epoetin

Amgen to buy kidney drug firm Ilypsa for USD 420m

Ilypsa's focus on renal disorders complements Amgen's existing drug portfolio, which includes Aranesp (darbepoetin alfa) and Epogen (epoetin alfa) artificial versions of human erythropoietin used to treat anaemia in

FDA approvable letter delays Mircera launch in US

The approvable letter provides breathing space to US-based competitor company Amgen, whose best-selling anaemia drugs are Epogen and Aranesp. ... Epogen, which is sold for dialysis use in the US, racked up sales of USD 2.5bn in FY06.

News in brief, May 09, 2007

Studies over the last six months showed that Epogen (epoetin alfa) and Aranesp (darbepoetin alfa) can raise the risk of heart attack, stroke and death.

News in brief, May 02, 2007

Amgen added it would reduce expenses and update its revenue forecast, due to studies into its two best-selling anaemia drugs, Aranesp and Epogen, showing that high doses increased risk of ... death. Aranesp and Epogen, which are also prescribed for

[ Previous 5 results ] 3 4 5 6 7 8 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...